Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-5-18
pubmed:abstractText
Indirect evidence suggests that the antidepressant venlafaxine hydrochloride selectively inhibits serotonin (5-HT) uptake at low doses, whereas at high doses, it inhibits both 5-HT and norepinephrine (NE) uptake. We hypothesized that, in vivo, both high and low doses would inhibit the 5-HT uptake of platelets but that the higher dose would differentially blunt the pressor response to tyramine, a marker for NE uptake.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0003-990X
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10807491-Adolescent, pubmed-meshheading:10807491-Adrenergic Uptake Inhibitors, pubmed-meshheading:10807491-Adult, pubmed-meshheading:10807491-Antidepressive Agents, Second-Generation, pubmed-meshheading:10807491-Biological Transport, Active, pubmed-meshheading:10807491-Blood Platelets, pubmed-meshheading:10807491-Blood Pressure, pubmed-meshheading:10807491-Cyclohexanols, pubmed-meshheading:10807491-Dose-Response Relationship, Drug, pubmed-meshheading:10807491-Electrocardiography, pubmed-meshheading:10807491-Heart Rate, pubmed-meshheading:10807491-Humans, pubmed-meshheading:10807491-Injections, Intravenous, pubmed-meshheading:10807491-Male, pubmed-meshheading:10807491-Maprotiline, pubmed-meshheading:10807491-Middle Aged, pubmed-meshheading:10807491-Norepinephrine, pubmed-meshheading:10807491-Serotonin, pubmed-meshheading:10807491-Serotonin Uptake Inhibitors, pubmed-meshheading:10807491-Sertraline, pubmed-meshheading:10807491-Systole, pubmed-meshheading:10807491-Tyramine
pubmed:year
2000
pubmed:articleTitle
Evidence of the dual mechanisms of action of venlafaxine.
pubmed:affiliation
Psychiatric Research Institute and the Department of Psychiatry, University of Kansas School of Medicine, Wichita 67214-2878, USA. aharvey@kumc.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't